Tickborne Complete 2.0 Panel Test
The most advanced and comprehensive screening available for tickborne diseases, utilizing cutting-edge silicon micro-array technology for unparalleled accuracy. This innovative test combines both antigen and PCR detection methods to identify Lyme disease, co-infections, and other tickborne illnesses with the highest specificity and sensitivity in the industry. By detecting both antibodies (IgG and IgM) and DNA of infectious organisms, this complete panel provides earlier, more accurate detection than traditional testing methods, allowing for faster intervention and better treatment outcomes. With tickborne diseases more than doubling in recent years and accounting for 77% of all vector-borne disease reports, accurate testing has never been more critical.
Who Needs It
This comprehensive testing panel is essential for anyone experiencing unexplained symptoms that could indicate a tickborne illness, particularly those with:
- Fever, chills, and flu-like symptoms
- Unexplained fatigue or muscle/joint pain
- Neurological symptoms including headaches, neck stiffness, or cognitive changes
- A known tick bite or potential exposure
- Rashes or skin changes
- Previous inconclusive Lyme testing
- Persistent symptoms despite negative traditional testing
- Multiple symptoms that have been difficult to diagnose
The test is especially valuable for those who live in or travel to tick-prevalent areas, outdoor enthusiasts, and anyone with unexplained chronic symptoms that haven’t been adequately diagnosed through conventional testing methods.
Why Do You Need It
Traditional tickborne disease testing often misses early infections and can give false negatives, leading to delayed treatment and chronic health issues. This advanced panel utilizes both antigen and PCR detection on a silicon micro-array platform, providing the highest sensitivity and specificity available. Catching these infections early is crucial – tickborne diseases can mimic many other conditions and, if left untreated, can lead to serious long-term health complications. Unlike standard testing that may only look for Lyme disease, this comprehensive panel screens for multiple tickborne infections simultaneously, including co-infections that can complicate treatment and recovery.
What You Need It For
The test results provide your healthcare provider with detailed insights about both active infections and previous exposure to tickborne diseases. This comprehensive data enables them to:
- Identify current infections requiring immediate treatment
- Detect multiple co-infections that may require different treatment approaches
- Distinguish between new and chronic infections
- Monitor treatment effectiveness with quantitative results
- Make informed decisions about appropriate antibiotic protocols
- Identify underlying infections that may be contributing to chronic symptoms
This advanced testing helps eliminate the guesswork in diagnosis and treatment planning, particularly for complex cases involving multiple infections or chronic symptoms.
Reviews
There are no reviews yet.